PENNVAX
Dead / Cancelled — Cancelled — Section 8 (as of 09 Oct 2018)
What this means for you
This registration has been cancelled; it no longer blocks anyone on its own. The name may be available, but check before relying on it — rights can also come from actual use, not only from the register.
Record
- Serial number
- 77333655
- Registration number
- 4002713
- Mark type
- Stylized text
- Filed
- 19 Nov 2007
- Published for opposition
- 14 Oct 2008
- Registered
- 26 Jul 2011
- Attorney of record
- Michael J. Leonard
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical compositions, namely, a nucleotide sequence that encodes an antigen, such as a DNA plasmid having an antigen encoding sequence and like DNA, for the prevention or treatment of acquired immunodeficiency syndrome (AIDS)
Owner
- INOVIO PHARMACEUTICALS, INC., Plymouth Meeting, PA, US
- VGX Pharmaceuticals, Inc., Blue Bell, PA, US
- VGX Pharmaceuticals, Inc., Blue Bell, PA, US
- VGX Pharmaceuticals, Inc., Blue Bell, PA, US
Prosecution history
- 09 Oct 2018 — CANCELLED SEC. 8 (6-YR)
- 20 Feb 2018 — POST REGISTRATION ACTION MAILED - SEC. 8
- 20 Feb 2018 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 26 Jan 2018 — TEAS SECTION 8 RECEIVED
- 23 Apr 2014 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 26 Jul 2011 — REGISTERED-PRINCIPAL REGISTER
- 21 Jun 2011 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 20 Jun 2011 — LAW OFFICE REGISTRATION REVIEW COMPLETED
- 16 Jun 2011 — ASSIGNED TO LIE
- 13 Jun 2011 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Jun 2011 — STATEMENT OF USE PROCESSING COMPLETE
- 03 Jun 2011 — USE AMENDMENT FILED
- 03 Jun 2011 — TEAS STATEMENT OF USE RECEIVED
- 11 Dec 2010 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 10 Dec 2010 — SOU EXTENSION 3 GRANTED